derazantinib,rly-4008
relay therapeutics,merck
['rly-4008', 'deraza']
at #esmo22, #fgfr inhibitors derazantinib and rly-4008 show potential for the treatment of #cholangiocarcinoma to know more 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.